A) | 5,9280 | ||
B) | 125,070 | ||
C) | 234,580 | ||
D) | 296,421 |
A) | Pollen | ||
B) | Nickel | ||
C) | Asbestos | ||
D) | Wood dust |
A) | adenocarcinoma. | ||
B) | oat cell carcinoma. | ||
C) | anaplastic carcinoma. | ||
D) | squamous cell carcinoma. |
A) | brain. | ||
B) | colon. | ||
C) | kidneys. | ||
D) | pancreas. |
A) | cough. | ||
B) | cyanosis. | ||
C) | weight loss. | ||
D) | shortness of breath. |
A) | viral meningitis. | ||
B) | the herpes virus. | ||
C) | elevated blood pressure due to kidney metastasis. | ||
D) | increased intracranial pressure due to brain metastasis. |
A) | is noninvasive. | ||
B) | does not allow for biopsies. | ||
C) | is done to assess mediastinal lymph nodes for possible metastasis. | ||
D) | relieves pressure resulting from superior vena cava syndrome. |
A) | N1. | ||
B) | N2. | ||
C) | N3. | ||
D) | NX. |
A) | fibrosarcoma. | ||
B) | adenocarcinoma. | ||
C) | malignant mesothelioma. | ||
D) | squamous cell carcinoma. |
A) | each mediastinal station. | ||
B) | stations 2R, 3, and 5. | ||
C) | stations 2R, 4R, 7, 8, and 9. | ||
D) | stations 4L, 5, 6, 7, 8, and 9. |
A) | metasteroids. | ||
B) | alkylating agents. | ||
C) | cell cycle phase specific. | ||
D) | cell cycle phase nonspecific. |
A) | Antiemetics after the infusion | ||
B) | Maintaining the patient NPO | ||
C) | Antiemetics prior to the infusion | ||
D) | Avoidance of foods with strong scents |
A) | Cough | ||
B) | Fatigue | ||
C) | Stomatitis | ||
D) | Weight gain |
A) | over the tattooed areas. | ||
B) | if they drink too much fluid. | ||
C) | if they have a fair complexion. | ||
D) | in areas where skin surfaces meet. |
A) | the cell type. | ||
B) | the extent of the disease. | ||
C) | the patient's physical condition at the time of diagnosis. | ||
D) | All of the above |
A) | metastasis to the heart. | ||
B) | fluid and electrolyte imbalances. | ||
C) | metastasis to the brain's respiratory center. | ||
D) | obstruction of airways and/or restriction of lung expansion. |
A) | oral. | ||
B) | intramuscular. | ||
C) | intravenous drip. | ||
D) | transdermal patch. |
A) | Dieting | ||
B) | Hypnosis | ||
C) | Biofeedback | ||
D) | Acupuncture |
A) | implanted ports. | ||
B) | tunneled catheters. | ||
C) | nontunneled catheters. | ||
D) | All of the above |
A) | Secure placement | ||
B) | Decreased risk of infection | ||
C) | Not visible outside the chest | ||
D) | Safe, reliable long-term access |
A) | Shock, denial, depression, anger, bargaining | ||
B) | Denial, anger, bargaining, depression, acceptance | ||
C) | Anger, denial, depression, bargaining, acceptance | ||
D) | There is no particular order; the patient may move back and forth between stages several times. |
A) | Anger | ||
B) | Denial | ||
C) | Bargaining | ||
D) | Acceptance |
A) | a living will. | ||
B) | a healthcare will. | ||
C) | habeus medicum. | ||
D) | a durable power of attorney for health care. |
A) | name their heirs. | ||
B) | surrender the right to be resuscitated. | ||
C) | specify what type of care they would and would not want. | ||
D) | turn over legal decisions regarding care to someone they trust. |
A) | provide for the best possible quality of life. | ||
B) | allow the patient to die surrounded by family. | ||
C) | assist the patient and family through the process of grief/loss. | ||
D) | All of the above |
A) | has Medicare. | ||
B) | has a 24-hour live-in caregiver. | ||
C) | has less than six months to live. | ||
D) | will never be hospitalized again. |
A) | controlling costs. | ||
B) | resource management. | ||
C) | high-quality patient care. | ||
D) | All of the above |
A) | should not be shown to patients. | ||
B) | are not that helpful for relief nurses. | ||
C) | are always a part of a patient's medical record. | ||
D) | have often been the catalyst for hospitals to move to a case management type of nursing. |
A) | is not very useful. | ||
B) | may be done prior to admission. | ||
C) | must be done the morning of surgery. | ||
D) | should not be started at the same time as other testing. |
A) | potential complications from the procedure. | ||
B) | medication schedules and possible side effects. | ||
C) | emergency telephone numbers and other safety information. | ||
D) | All of the above |